TP53 and cancer: It can serve as a predictor of ICI therapy effectiveness; moreover, p53 mutation-associated genome instability plays a positive role in ICI therapy.198, 199, 200 ICIs represent a popular oncological treatment modality in recent years and have shown improved efficacy in melanoma and other cancers, although the effective rate for all tumors is still insufficient.201